Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

6.66
Delayed Data
As of Feb 24
 +0.08 / +1.22%
Today’s Change
4.00
Today|||52-Week Range
7.51
-4.03%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close6.58
Today’s open6.54
Day’s range6.51 - 6.67
Volume74,590
Average volume (3 months)169,163
Market cap$308.3M
Dividend yield--
Data as of 4:02pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+5.30%
P/E ratio7.9
Price/Sales3.16
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
RDNTRadNet Inc-0.10-1.65%
PTIProteostasis Therape...-0.04-0.27%
CCMConcord Medical Serv...-0.04-0.81%
NVTAInvitae Corp-0.04-0.39%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$102.8M
Annual profit (last year)$45.3M
Net profit margin44.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer &
Class II Director
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts


Search for Jobs